Hyperfine (HYPR) announced it has received CE Marking and UK Conformity Assessment approval for its Optive AI software. These approvals, which closely follow the FDA clearance, deliver a substantial leap in image quality for the Swoop portable MRI system and expand international access to the latest Hyperfine AI-powered imaging software. Together, they mark a pivotal step in the company’s ongoing commercial expansion across international markets.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HYPR: